UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis

Journal of the American Academy of Dermatology, 2013-09, Vol.69 (3), p.416-425.e1

2013

Volltextzugriff (PDF)

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

The New England journal of medicine, 2014-07, Vol.371 (4), p.326-338

2014

Volltextzugriff (PDF)

Effective treatment with balneophototherapy and narrowband UVB monotherapy reduces skin homing Th17/Tc17 and Th22/Tc22 effector cells in peripheral blood in patients with psoriasis

Journal of dermatological science, 2019-11, Vol.96 (2), p.110-112

2019

Volltextzugriff (PDF)

Psoriasis treatment: faster and long-standing results after bathing in geothermal seawater. A randomized trial of three UVB phototherapy regimens

Photodermatology, photoimmunology & photomedicine, 2014-02, Vol.30 (1), p.25-34

2014

Volltextzugriff (PDF)

Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials

International journal of dermatology, 2016-04, Vol.55 (4), p.401-407

2016

Volltextzugriff (PDF)

Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma

Nature communications, 2020-02, Vol.11 (1), p.820-820, Article 820

2020

Volltextzugriff (PDF)

Therapeutic potential of TDT 067 (terbinafine in Transfersome®): a carrier-based dosage form of terbinafine for onychomycosis

Expert opinion on investigational drugs, 2012-10, Vol.21 (10), p.1549-1562

2012

Volltextzugriff (PDF)

Comparison of pharmacokinetics, safety and tolerability of secukinumab administered subcutaneously using different delivery systems in healthy volunteers and in psoriasis patients

British journal of clinical pharmacology, 2020-02, Vol.86 (2), p.338-351

2020

Volltextzugriff (PDF)

Genetic determinants of hair, eye and skin pigmentation in Europeans

Nature genetics, 2007-12, Vol.39 (12), p.1443-1452

2007

Volltextzugriff (PDF)

Onychomycosis: Diagnosis and definition of cure

Journal of the American Academy of Dermatology, 2007-06, Vol.56 (6), p.939-944

2007

Volltextzugriff (PDF)

HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series

Journal of the American Academy of Dermatology, 2016-11, Vol.75 (5), p.889-896

2016

Volltextzugriff (PDF)

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis

BMJ, 1999-04, Vol.318 (7190), p.1031-1035

International edition, 1999

Volltextzugriff (PDF)

Mælingar á roðavaldandi geislum sólarinnar sumarið 2010

Laeknabladid, 2011-07, Vol.2011 (708), p.413-416

2011

Volltextzugriff (PDF)

Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study

Dermatology (Basel), 2004-01, Vol.209 (4), p.301-307

2004

Volltextzugriff (PDF)

Authors’ Response

Pediatrics (Evanston), 2015-11, Vol.136 (5), p.e1485-e1486

2015

Volltextzugriff (PDF)

Roðavaldandi geislar sólarinnar og þýðing þeirra

Laeknabladid, 2011-07, Vol.2011 (708), p.417-420

2011

Volltextzugriff (PDF)

Patient‐reported outcomes from two randomised studies comparing once‐weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis

Mycoses, 2017-12, Vol.60 (12), p.800-807

2017

Volltextzugriff (PDF)

Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial

Pediatrics (Evanston), 2015-04, Vol.135 (4), p.597-606

2015

Volltextzugriff (PDF)

FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease

Nature (London), 2020-08, Vol.584 (7822), p.619-623

2020

Volltextzugriff (PDF)

Systemic Therapy of Onychomycosis

Scher and Daniel's Nails, 2018, p.185-214

2018

Volltextzugriff (PDF)

Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials

British journal of dermatology (1951), 2023-02, Vol.188 (2), p.198-207

2023

Volltextzugriff (PDF)

The darker side of tanning [Editorial.

Laeknabladid, 2004-07, Vol.90 (7-8), p.536-538

Sigurgeirsson, Bárður

2004

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Effective treatment with balneophototherapy and narrowband UVB monotherapy reduces skin homing Th17/Tc17 and Th22/Tc22 effector cells in peripheral blood in patients with psoriasis

Psoriasis treatment: faster and long-standing results after bathing in geothermal seawater. A randomized trial of three UVB phototherapy regimens

Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials

Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma

Therapeutic potential of TDT 067 (terbinafine in Transfersome®): a carrier-based dosage form of terbinafine for onychomycosis

Comparison of pharmacokinetics, safety and tolerability of secukinumab administered subcutaneously using different delivery systems in healthy volunteers and in psoriasis patients

Genetic determinants of hair, eye and skin pigmentation in Europeans

Onychomycosis: Diagnosis and definition of cure

Two newly identified genetic determinants of pigmentation in Europeans

HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series

Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis

Mælingar á roðavaldandi geislum sólarinnar sumarið 2010

Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study

Authors’ Response

Roðavaldandi geislar sólarinnar og þýðing þeirra

Patient‐reported outcomes from two randomised studies comparing once‐weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis

Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial

FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease

Systemic Therapy of Onychomycosis

Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials

The darker side of tanning [Editorial.

Parental origin of sequence variants associated with complex diseases

Suchergebnisse filtern